Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MK-6070 by Merck for Small-Cell Lung Cancer: Likelihood of Approval
MK-6070 is under clinical development by Merck and currently in Phase II for Small-Cell Lung Cancer. According to GlobalData, Phase...
MK-6070 by Merck for Prostate Cancer: Likelihood of Approval
MK-6070 is under clinical development by Merck and currently in Phase II for Prostate Cancer. According to GlobalData, Phase II...
MK-6070 by Merck for Colorectal Cancer: Likelihood of Approval
MK-6070 is under clinical development by Merck and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase II...
MK-6070 by Merck for Pancreatic Cancer: Likelihood of Approval
MK-6070 is under clinical development by Merck and currently in Phase II for Pancreatic Cancer. According to GlobalData, Phase II...
MK-6070 by Merck for Bladder Cancer: Likelihood of Approval
MK-6070 is under clinical development by Merck and currently in Phase II for Bladder Cancer. According to GlobalData, Phase II...
MK-6070 by Merck for Thymic Carcinoma: Likelihood of Approval
MK-6070 is under clinical development by Merck and currently in Phase II for Thymic Carcinoma. According to GlobalData, Phase II...